Resources from the same session
Tumour board discussion
Presenter: Kim Chi
Session: Genitourinary tumours
Treatment of locally recurrent prostate cancer following external beam radiotherapy or brachytherapy: In situ gene therapy with iodine-131 and the sodium iodide symporter gene
Presenter: Brian Davis
Session: Genitourinary tumours
Resources:
Abstract
The prognostic significance of neutrophil to lymphocyte ratio and platelet count in patients with metastatic urothelial carcinoma
Presenter: Yu Li Su
Session: Genitourinary tumours
Resources:
Abstract
Subgroup analysis of Asian men in the PREVAIL trial of enzalutamide (ENZA) in men with chemotherapy-naïve, metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Edmund Chiong
Session: Genitourinary tumours
Resources:
Abstract
RECORD-4: Multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis
Presenter: Lin Yang
Session: Genitourinary tumours
Resources:
Abstract
Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma
Presenter: Mian Xie
Session: Genitourinary tumours
Resources:
Abstract
Phase 3 study of radium-223 dichloride (Ra-223) in Asian patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets)
Presenter: Yinghao Sun
Session: Genitourinary tumours
Resources:
Abstract
Medical treatment of mRCC
Presenter: Yoshihiko Tomita
Session: Genitourinary tumours
Invited discussant abstracts 240PD, 241PD, 242PD and 243PD
Presenter: Oliver Sartor
Session: Genitourinary tumours
Invited discussant abstracts 236O and 237O
Presenter: Joaquim Bellmunt
Session: Genitourinary tumours